Butein
Butein is a cAMP-specific PDE inhibitor with an IC50 of 10.4 μM for PDE4[1]. Butein is a specific protein tyrosine kinase inhibitor with IC50s of 16 and 65 μM for EGFR and p60c-src in HepG2 cells[2]. Butein sensitizes HeLa cells to Cisplatin through AKT and ERK/p38 MAPK pathways by targeting FoxO3a[3]. Butein is a SIRT1 activator (STAC) .
Product Specifications
CAS Number
487-52-5
Product Name Alternative
2’,3,4,4’-tetrahydroxy Chalcone
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy; EGFR; Phosphodiesterase (PDE)
Type
Natural Products
Related Pathways
Apoptosis; Autophagy; JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Butein.html
Purity
99.64
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC1=CC=C(C(/C=C/C2=CC(O)=C(O)C=C2)=O)C(O)=C1
Molecular Formula
C15H12O5
Molecular Weight
272.25
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
EGFR/ErbB1/HER1; PDE4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Zfp970 shRNA (UAS) - Lentiviral mouse Zfp970 shRNA (UAS) (25)
VLDL Receptor Rabbit Polyclonal Antibody (PerCP-Cy7)
SYRINGE FLTR 25MM FLL/MLS PP PVDF 0.45UM CLR 100PK
Phospho-c-Jun (Thr91+Thr93) Recombinant Antibody, RBITC Conjugated
Annexin II (ANXA2, Lipocortin 2) (MaxLight 750) discontinued